Showing results (2591-2600 of 3,253) with videos related to

Sort By:
Pageof 326
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|March 9, 2017
[Ventilator-associated pneumonia among premature infants <34 weeks' gestational age in neonatal intensive care unit in China: a multicenter study]S J Li, S Y Yan, Y Zhou, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|July 12, 2024
A Multicenter Training and Interrater Reliability Study of the BASED Score for Infantile Epileptic Spasms SyndromeJohn R Mytinger, Dara V F Albert, Shawn C Aylward, et al.
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|February 26, 2025
A Multicenter Training and Interrater Reliability Study of the BASED Score for Infantile Epileptic Spasms SyndromeJohn R Mytinger, Dara V F Albert, Shawn C Aylward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2025
Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancerK Laktionov, A Smolin, D Stroyakovskiy, et al.
Nature Biotechnology|October 10, 2022
A proteome-scale map of the SARS-CoV-2-human contactomeDae-Kyum Kim, Benjamin Weller, Chung-Wen Lin, et al.
Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology|November 27, 2025
[Consensus on informed consent for orthodontic treatment]Y Cao, B Fang, Z L Jin, et al.
Hand Surgery & Rehabilitation|April 13, 2020
COVID-19: Initial experience of an international group of hand surgeonsF Ducournau, M Arianni, S Awwad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2014
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesT Moran, J Wei, M Cobo, et al.
Pageof 326